Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

M Schuler; R Berardi; WT Lim; Maja de Jonge; TM Bauer; A Azaro; M Gottfried; JY Han; D H Lee; M Wollner; DS Hong; A Vogel; A Delmonte; M Akimov; S Ghebremariam; X Cui; N Nwana; M Giovannini; TM Kim

doi:10.1016/j.annonc.2020.03.293

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

M Schuler, R Berardi, WT Lim, Maja de Jonge, TM Bauer, A Azaro, M Gottfried, JY Han, D H Lee, M Wollner, DS Hong, A Vogel, A Delmonte, M Akimov, S Ghebremariam, X Cui, N Nwana, M Giovannini, TM Kim

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

43 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	789-797
Number of pages	9
Journal	Annals of Oncology
Volume	31
Issue number	6
DOIs	https://doi.org/10.1016/j.annonc.2020.03.293
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2020.03.293

Repub_126558_O-A.pdfFinal published version, 559 KB

Cite this

Schuler, M., Berardi, R., Lim, WT., de Jonge, M., Bauer, TM., Azaro, A., Gottfried, M., Han, JY., Lee, D. H., Wollner, M., Hong, DS., Vogel, A., Delmonte, A., Akimov, M., Ghebremariam, S., Cui, X., Nwana, N., Giovannini, M., & Kim, TM. (2020). Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial. Annals of Oncology, 31(6), 789-797. https://doi.org/10.1016/j.annonc.2020.03.293

@article{191d539f052e45e18b156704259ceead,

title = "Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial",

author = "M Schuler and R Berardi and WT Lim and {de Jonge}, Maja and TM Bauer and A Azaro and M Gottfried and JY Han and Lee, {D H} and M Wollner and DS Hong and A Vogel and A Delmonte and M Akimov and S Ghebremariam and X Cui and N Nwana and M Giovannini and TM Kim",

year = "2020",

doi = "10.1016/j.annonc.2020.03.293",

language = "English",

volume = "31",

pages = "789--797",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "6",

}

Schuler, M, Berardi, R, Lim, WT, de Jonge, M, Bauer, TM, Azaro, A, Gottfried, M, Han, JY, Lee, DH, Wollner, M, Hong, DS, Vogel, A, Delmonte, A, Akimov, M, Ghebremariam, S, Cui, X, Nwana, N, Giovannini, M & Kim, TM 2020, 'Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial', Annals of Oncology, vol. 31, no. 6, pp. 789-797. https://doi.org/10.1016/j.annonc.2020.03.293

TY - JOUR

T1 - Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

AU - Schuler, M

AU - Berardi, R

AU - Lim, WT

AU - de Jonge, Maja

AU - Bauer, TM

AU - Azaro, A

AU - Gottfried, M

AU - Han, JY

AU - Lee, D H

AU - Wollner, M

AU - Hong, DS

AU - Vogel, A

AU - Delmonte, A

AU - Akimov, M

AU - Ghebremariam, S

AU - Cui, X

AU - Nwana, N

AU - Giovannini, M

AU - Kim, TM

PY - 2020

Y1 - 2020

U2 - 10.1016/j.annonc.2020.03.293

DO - 10.1016/j.annonc.2020.03.293

M3 - Article

VL - 31

SP - 789

EP - 797

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 6

ER -